Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Janux Therapeutics
(NASDAQ:JANX)
Intraday
$48.88
0
[0.00%]
After-Hours
$48.88
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$48.88
0
[0.00%]
At close: Apr 22
$48.88
0
[0.00%]
PreMarket: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Janux Therapeutics Stock (NASDAQ:JANX)
Janux Therapeutics Stock (NASDAQ: JANX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 16, 2024
A Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts
Benzinga Insights
-
Apr 16, 2024, 8:00AM
JonesTrading Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $70
Benzinga Newsdesk
-
Apr 16, 2024, 6:50AM
Friday, April 12, 2024
Janux Therapeutics shares are trading higher on continued strength following Wednesday reports suggesting the company is said to weigh a possible sale.
Benzinga Newsdesk
-
Apr 12, 2024, 10:29AM
Thursday, April 11, 2024
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Apr 11, 2024, 1:33PM
Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?
Vandana Singh
-
Apr 11, 2024, 12:13PM
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
-
Apr 11, 2024, 10:01AM
Janux Therapeutics shares are trading higher following Wednesday reports suggesting the company is said to weigh a possible sale.
Benzinga Newsdesk
-
Apr 11, 2024, 7:13AM
Wednesday, April 10, 2024
Janux Therapeutics shares are trading higher amid reports suggesting the company is said to weigh a possible sale.
Benzinga Newsdesk
-
Apr 10, 2024, 3:07PM
Janux Therapeutics Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 18%
Benzinga Newsdesk
-
Apr 10, 2024, 1:48PM
"Drugmaker Janux Therapeutics Said To Weigh Possible Sale"
Benzinga Newsdesk
-
Apr 10, 2024, 1:43PM
Thursday, April 04, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Apr 4, 2024, 1:35PM
Thursday, March 21, 2024
BTIG Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $62
Benzinga Newsdesk
-
Mar 21, 2024, 6:00AM
Wednesday, March 20, 2024
Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst
Vandana Singh
-
Mar 20, 2024, 1:44PM
Forecasting The Future: 4 Analyst Projections For Janux Therapeutics
Benzinga Insights
-
Mar 20, 2024, 10:00AM
Cantor Fitzgerald Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $100
Benzinga Newsdesk
-
Mar 20, 2024, 5:24AM
Wednesday, March 13, 2024
B of A Securities Maintains Buy Rating for Janux Therapeutics: Here's What You Need To Know
Benzinga Insights
-
Mar 13, 2024, 1:00PM
B of A Securities Maintains Buy on Janux Therapeutics, Raises Price Target to $48
Benzinga Newsdesk
-
Mar 13, 2024, 10:31AM
Tuesday, March 12, 2024
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Mar 12, 2024, 2:07PM
Monday, March 11, 2024
HC Wainwright & Co. Maintains Buy on Janux Therapeutics, Raises Price Target to $50
Benzinga Newsdesk
-
Mar 11, 2024, 6:38AM
Friday, March 08, 2024
Janux Therapeutics Q4 EPS $(0.25) Beats $(0.41) Estimate, Sales $2.46M Beat $740.00K Estimate
Benzinga Newsdesk
-
Mar 8, 2024, 4:15PM
Thursday, February 29, 2024
Janux Therapeutics Prices $296.5M Underwritten Public Offering of Common Stock and Pre-Funded Warrants at $46.50/Share
Benzinga Newsdesk
-
Feb 29, 2024, 2:06AM
Tuesday, February 27, 2024
Janux Therapeutics Announces Proposed $175M Public Offering of Common Stock
Benzinga Newsdesk
-
Feb 27, 2024, 5:50PM
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings
Avi Kapoor
-
Feb 27, 2024, 2:32PM
S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday?
Piero Cingari
-
Feb 27, 2024, 2:18PM
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Feb 27, 2024, 1:18PM
Cancer-Focused Janux Therapeutics Stock Remains Undervalued Despite Price Surge After Study Data: Analyst
Vandana Singh
-
Feb 27, 2024, 12:41PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Feb 27, 2024, 12:31PM
Crude Oil Gains 1%; Macy's Plans To Close 150 Stores
Avi Kapoor
-
Feb 27, 2024, 12:24PM
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
-
Feb 27, 2024, 10:27AM
Nasdaq Rises 50 Points; Lowe's Earnings Top Views
Avi Kapoor
-
Feb 27, 2024, 9:42AM
Wedbush Maintains Outperform on Janux Therapeutics, Raises Price Target to $53
Benzinga Newsdesk
-
Feb 27, 2024, 8:56AM
Market-Moving News for February 27th
Benzinga Newsdesk
-
Feb 27, 2024, 8:44AM
Janux shares are trading higher after the company announced updated clinical data for both of its clinical programs.
Benzinga Newsdesk
-
Feb 27, 2024, 8:31AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Feb 27, 2024, 8:06AM
Why TransMedics Group Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 27, 2024, 7:56AM
Monday, February 26, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Feb 26, 2024, 4:31PM
Janux shares are trading higher after the company announced updated clinical data for both of its clinical programs.
Benzinga Newsdesk
-
Feb 26, 2024, 4:27PM
Janux Says 83% (5/6) Of Subjects Achieved PSA50 Declines With First Step Dose ≥ 0.2mg; 56% (10/18) Of Subjects Achieved PSA50 Declines With First Dose ≥ 0.1mg
Benzinga Newsdesk
-
Feb 26, 2024, 4:21PM
Janux Announces Safety And Efficacy Data In Ongoing Dose Escalation Trials For PSMAxCD3-TRACTr JANX007 In mCRPC And EGFRxCD3-TRACTr JANX008 In Solid Tumors
Benzinga Newsdesk
-
Feb 26, 2024, 4:20PM
Thursday, February 22, 2024
Janux Therapeutics Filed U.S. Patent Application #20240059790: Compositions And Methods Related To Tumor Activated Antibodies Targeting PSMA And Effector Cell Antigens
Charles Gross
-
Feb 22, 2024, 2:33PM
Wednesday, February 21, 2024
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Feb 21, 2024, 1:50PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Feb 21, 2024, 12:31PM
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Feb 21, 2024, 10:47AM
Tuesday, February 20, 2024
Janux Therapeutics To Host Virtual Event On Monday, February 26th, 2024, At 4:30PM ET To Discuss Updated Clinical Data For PSMA-TRACTr JANX007 And EGFR-TRACTr JANX008
Benzinga Newsdesk
-
Feb 20, 2024, 8:27AM
Monday, February 12, 2024
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Feb 12, 2024, 1:07PM
Thursday, November 16, 2023
Massive Insider Trade At Janux Therapeutics
Benzinga Insights
-
Nov 16, 2023, 10:04AM
Tuesday, November 14, 2023
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Nov 14, 2023, 2:05PM
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Nov 14, 2023, 10:39AM
Janux Therapeutics Insider Trades Send a Signal
Benzinga Insights
-
Nov 14, 2023, 10:01AM
$27.5M Bet On Block? Check Out These 3 Stocks Insiders Are Buying
Lisa Levin
-
Nov 14, 2023, 8:23AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch